Alzheimer’s with Agitation
A clinical trial of an investigational medication for treating agitation symptoms related to Alzheimer’s or dementia.
Unpredictable, agitated behavior due to Alzheimer’s can be frustrating.
If you are caring for a loved one that has agitation symptoms due to Alzheimer’s disease, consider this clinical trial.
Agitation due to Alzheimer’s disease can be extremely disruptive and potentially harmful to you and your loved one. Aggression, which can be both physical and verbal, is one of the most common expressions of agitation. Unpredictable outbursts can make caring for your loved one intimidating and stressful. Agitation can be defined as the presence of one of the following behaviors: pacing, wandering, repetitive questions or mannerisms, yelling, shouting, restlessness, physical or verbal aggression.
IPS Research is seeking participants for a clinical trial of an investigational medication for treating agitation symptoms related to Alzheimer’s or dementia.
To be eligible for this study, patients must:
- Be at least 55 years of age
- Have diagnosis of Alzheimer’s disease or dementia
- Have agitation symptoms present at least 3 times a week
- Have a caregiver able to attend all study visits
Qualified participants may receive:
- Study-related medical exams, study drug and assessments at no cost
- Compensation for time and travel